45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
○Discounted cash price: below assessment threshold
●Payer-specific negotiated rates: assessment threshold met
●Min / max negotiated charges: assessment threshold met
●Free, public, no login required: assessment threshold met
Procedures listed
14,783
Insurances with rates
4
CPT / HCPCS codes
6,064
Most expensive procedures (gross)
63601326
$2,132,044
Hc Breyanzi Car-T
Gross
$2,842,725
63601357
$2,094,746
Hc Carvykti Car-T
Gross
$2,792,994
63601421
$1,833,476
Hc Dfci Kymriah Car-T
Gross
$2,444,634
197072
$180,840
LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION
Gross
$241,120
104852
$159,729
SIPULEUCEL-T IN LACTATED RINGERS 50 MILLION CELL/250 ML IV SUSPENSION
Gross
$212,972
210623
$143,055
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 27 MCI/ML (1,000 MBQ/ML) IV SOLN
Gross
$190,740
108956
$142,052
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$189,402
81900006
$140,010
Hc Unrelated Bmt Donor Acq Fee
Gross
$186,680
201095
$135,449
TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION
Gross
$180,598
7002610
$118,131
TAGRAXOFUSP-ERZS (ELZONRIS) SYRINGE 100 MCG/ML CMPD
Gross
$157,507
203026
$116,507
CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION
Gross
$155,343
76002029
$111,416
Hc Dfci Stem Cell Rescue
Gross
$148,554
207651
$111,413
LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION
Gross
$148,550
12519
$107,596
PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION
Gross
$143,461
207211
$96,902
TIVOZANIB 0.89 MG CAPSULE
Gross
$129,203
207212
$96,902
TIVOZANIB 1.34 MG CAPSULE
Gross
$129,203
201872
$96,103
RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION
Gross
$128,138
202233
$92,600
SELINEXOR 80 MG TWICE WEEKLY (160 MG/WEEK) (20 MG X 8) TABLET
Gross
$123,466
195366
$91,643
INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN
Gross
$122,190
76002028
$87,289
Hc Dfci Donor Lymphocyte Collection
Gross
$116,386
214056
$84,010
PIRTOBRUTINIB 100 MG TABLET
Gross
$112,013
210083
$81,929
TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION
Gross
$109,239
210516
$78,244
PACRITINIB 100 MG CAPSULE
Gross
$104,325
213430
$74,919
MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION
Gross
$99,892
201916
$74,454
POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION
Gross
$99,272
81500001
$74,250
Hc Related Bmt Donor Acq Fee
Gross
$99,000
206491
$71,876
PONATINIB 30 MG TABLET
Gross
$95,835
206588
$71,876
PONATINIB 10 MG TABLET
Gross
$95,835
7008151
$71,823
SOTORASIB 120 MG TABLET
Gross
$95,765
209444
$71,823
ASCIMINIB 40 MG TABLET
Gross
$95,764
200177
$71,307
GLASDEGIB 25 MG TABLET
Gross
$95,076
200178
$71,307
GLASDEGIB 100 MG TABLET
Gross
$95,076
199033
$68,958
TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE
Gross
$91,944
196364
$65,296
EMICIZUMAB-KXWH 150 MG/ML SUBCUTANEOUS SOLUTION
Gross
$87,061
214895
$64,636
EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION
Gross
$86,182
189366
$63,868
CABOZANTINIB 60 MG TABLET
Gross
$85,158
204076
$62,210
TAZEMETOSTAT 200 MG TABLET
Gross
$82,946
208564
$62,194
BELUMOSUDIL 200 MG TABLET
Gross
$82,925
210457
$60,485
NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION
Gross
$80,647
218649
$60,007
TARLATAMAB-DLLE 10 MG INTRAVENOUS SOLUTION
Gross
$80,009
105644
$57,442
CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION
Gross
$76,589
197973
$56,296
BUROSUMAB-TWZA 30 MG/ML SUBCUTANEOUS SOLUTION
Gross
$75,061
9513
$53,888
CHLORAMBUCIL 2 MG TABLET
Gross
$71,850
173280
$52,114
FACTOR IX RECOMB, FC FUSION PROTEIN 3,000 UNIT INTRAVENOUS SOLUTION
Gross
$69,486
169403
$51,705
IBRUTINIB 140 MG CAPSULE
Gross
$68,940
7008982
$50,662
PERTUZUMAB 1,200 MG-TRASTUZUMAB 600 MG-HYALURON-ZZXF/15 ML SUBCUT SOLN
Gross
$67,549
111348
$48,953
BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION
Gross
$65,270
203477
$48,395
LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION
Gross
$64,527
220765
$47,648
ZENOCUTUZUMAB-ZBCO 375 MG/18.75 ML (20 MG/ML) INTRAVENOUS SOLUTION
Gross
$63,531
207659
$47,183
DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION
Gross
$62,911
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 63601326 | Hc Breyanzi Car-T | $2,842,725 | $2,132,044 | — | — | 0 |
| 63601357 | Hc Carvykti Car-T | $2,792,994 | $2,094,746 | — | — | 0 |
| 63601421 | Hc Dfci Kymriah Car-T | $2,444,634 | $1,833,476 | — | — | 0 |
| 197072 | LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION | $241,120 | $180,840 | — | — | 0 |
| 104852 | SIPULEUCEL-T IN LACTATED RINGERS 50 MILLION CELL/250 ML IV SUSPENSION | $212,972 | $159,729 | — | — | 0 |
| 210623 | LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 27 MCI/ML (1,000 MBQ/ML) IV SOLN | $190,740 | $143,055 | — | — | 0 |
| 108956 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $189,402 | $142,052 | — | — | 0 |
| 81900006 | Hc Unrelated Bmt Donor Acq Fee | $186,680 | $140,010 | — | — | 0 |
| 201095 | TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION | $180,598 | $135,449 | — | — | 0 |
| 7002610 | TAGRAXOFUSP-ERZS (ELZONRIS) SYRINGE 100 MCG/ML CMPD | $157,507 | $118,131 | — | — | 0 |
| 203026 | CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION | $155,343 | $116,507 | — | — | 0 |
| 76002029 | Hc Dfci Stem Cell Rescue | $148,554 | $111,416 | — | — | 0 |
| 207651 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $148,550 | $111,413 | — | — | 0 |
| 12519 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $143,461 | $107,596 | — | — | 0 |
| 207211 | TIVOZANIB 0.89 MG CAPSULE | $129,203 | $96,902 | — | — | 0 |
| 207212 | TIVOZANIB 1.34 MG CAPSULE | $129,203 | $96,902 | — | — | 0 |
| 201872 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION | $128,138 | $96,103 | — | — | 0 |
| 202233 | SELINEXOR 80 MG TWICE WEEKLY (160 MG/WEEK) (20 MG X 8) TABLET | $123,466 | $92,600 | — | — | 0 |
| 195366 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $122,190 | $91,643 | — | — | 0 |
| 76002028 | Hc Dfci Donor Lymphocyte Collection | $116,386 | $87,289 | — | — | 0 |
| 214056 | PIRTOBRUTINIB 100 MG TABLET | $112,013 | $84,010 | — | — | 0 |
| 210083 | TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION | $109,239 | $81,929 | — | — | 0 |
| 210516 | PACRITINIB 100 MG CAPSULE | $104,325 | $78,244 | — | — | 0 |
| 213430 | MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION | $99,892 | $74,919 | — | — | 0 |
| 201916 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $99,272 | $74,454 | — | — | 0 |
| 81500001 | Hc Related Bmt Donor Acq Fee | $99,000 | $74,250 | — | — | 0 |
| 206491 | PONATINIB 30 MG TABLET | $95,835 | $71,876 | — | — | 0 |
| 206588 | PONATINIB 10 MG TABLET | $95,835 | $71,876 | — | — | 0 |
| 7008151 | SOTORASIB 120 MG TABLET | $95,765 | $71,823 | — | — | 0 |
| 209444 | ASCIMINIB 40 MG TABLET | $95,764 | $71,823 | — | — | 0 |
| 200177 | GLASDEGIB 25 MG TABLET | $95,076 | $71,307 | — | — | 0 |
| 200178 | GLASDEGIB 100 MG TABLET | $95,076 | $71,307 | — | — | 0 |
| 199033 | TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE | $91,944 | $68,958 | — | — | 0 |
| 196364 | EMICIZUMAB-KXWH 150 MG/ML SUBCUTANEOUS SOLUTION | $87,061 | $65,296 | — | — | 0 |
| 214895 | EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION | $86,182 | $64,636 | — | — | 0 |
| 189366 | CABOZANTINIB 60 MG TABLET | $85,158 | $63,868 | — | — | 0 |
| 204076 | TAZEMETOSTAT 200 MG TABLET | $82,946 | $62,210 | — | — | 0 |
| 208564 | BELUMOSUDIL 200 MG TABLET | $82,925 | $62,194 | — | — | 0 |
| 210457 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $80,647 | $60,485 | — | — | 0 |
| 218649 | TARLATAMAB-DLLE 10 MG INTRAVENOUS SOLUTION | $80,009 | $60,007 | — | — | 0 |
| 105644 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $76,589 | $57,442 | — | — | 0 |
| 197973 | BUROSUMAB-TWZA 30 MG/ML SUBCUTANEOUS SOLUTION | $75,061 | $56,296 | — | — | 0 |
| 9513 | CHLORAMBUCIL 2 MG TABLET | $71,850 | $53,888 | — | — | 0 |
| 173280 | FACTOR IX RECOMB, FC FUSION PROTEIN 3,000 UNIT INTRAVENOUS SOLUTION | $69,486 | $52,114 | — | — | 0 |
| 169403 | IBRUTINIB 140 MG CAPSULE | $68,940 | $51,705 | — | — | 0 |
| 7008982 | PERTUZUMAB 1,200 MG-TRASTUZUMAB 600 MG-HYALURON-ZZXF/15 ML SUBCUT SOLN | $67,549 | $50,662 | — | — | 0 |
| 111348 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $65,270 | $48,953 | — | — | 0 |
| 203477 | LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION | $64,527 | $48,395 | — | — | 0 |
| 220765 | ZENOCUTUZUMAB-ZBCO 375 MG/18.75 ML (20 MG/ML) INTRAVENOUS SOLUTION | $63,531 | $47,648 | — | — | 0 |
| 207659 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $62,911 | $47,183 | — | — | 0 |
Showing top 50 of 14,783 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.